Polar Capital Holdings Plc - Q2 2023 holdings

$19.8 Billion is the total value of Polar Capital Holdings Plc's 286 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was - .

 Value Shares↓ Weighting
NewDISC MEDICINE INCcall$1,894,157,28042,661,200
+100.0%
9.55%
MMYT NewMAKEMYTRIP LIMITED MAURITIUScall$1,593,182,49059,050,500
+100.0%
8.04%
MCK NewMCKESSON CORP$136,975,075320,552
+100.0%
0.69%
SNPS NewSYNOPSYS INC$134,422,823308,727
+100.0%
0.68%
RMBS NewRAMBUS INC DEL$84,005,7811,309,113
+100.0%
0.42%
FN NewFABRINET$73,479,090565,746
+100.0%
0.37%
NewINDIVIOR PLCord$72,582,5503,049,687
+100.0%
0.37%
MNDY NewMONDAY COM LTD$48,309,894282,151
+100.0%
0.24%
TDC NewTERADATA CORP DEL$48,084,970900,299
+100.0%
0.24%
BDX NewBECTON DICKINSON & CO$35,640,294134,996
+100.0%
0.18%
NBIX NewNEUROCRINE BIOSCIENCES INC$35,362,500375,000
+100.0%
0.18%
KRTX NewKARUNA THERAPEUTICS INC$32,841,933151,450
+100.0%
0.17%
BPMC NewBLUEPRINT MEDICINES CORP$31,600,000500,000
+100.0%
0.16%
ANSS NewANSYS INC$22,853,36369,196
+100.0%
0.12%
DDOG NewDATADOG INC$22,751,851231,265
+100.0%
0.12%
NewASCENDIS PHARMA A/Snote 2.250% 4/0$21,900,00024,000,000
+100.0%
0.11%
ESTA NewESTABLISHMENT LABS HLDGS INC$15,707,848228,944
+100.0%
0.08%
BKI NewBLACK KNIGHT INC$14,772,125247,315
+100.0%
0.08%
NewEXACT SCIENCES CORPnote 0.375% 3/1$12,952,50012,000,000
+100.0%
0.06%
AXP NewAMERICAN EXPRESS CO$10,669,40261,248
+100.0%
0.05%
FROG NewJFROG LTD$10,534,670380,313
+100.0%
0.05%
XFOR NewX4 PHARMACEUTICALS INCcall$9,700,0005,000,000
+100.0%
0.05%
NewNATIONAL VISION HLDGS INCnote 2.500% 5/1$9,432,0009,000,000
+100.0%
0.05%
CCEP NewCOCA-COLA EUROPACIFIC PARTNE$8,141,310126,359
+100.0%
0.04%
DYN NewDYNE THERAPEUTICS INC$5,625,000500,000
+100.0%
0.03%
NewETSY INCnote 0.125% 9/0$5,450,4386,500,000
+100.0%
0.03%
NewBOOKING HOLDINGS INCnote 0.750% 5/0$5,263,3003,500,000
+100.0%
0.03%
NewDATADOG INCnote 0.125% 6/1$4,984,0004,000,000
+100.0%
0.02%
SQM NewSOCIEDAD QUIMICA Y MINERA DEspon adr ser b$4,429,82061,000
+100.0%
0.02%
NewLUMENTUM HLDGS INCnote 0.250% 3/1$4,248,0004,000,000
+100.0%
0.02%
NewATLASSIAN CORPORATIONcl a$4,203,30525,048
+100.0%
0.02%
AAPL NewAPPLE INCcall$4,247,94221,900
+100.0%
0.02%
NewCINEMARK HLDGS INCnote 4.500% 8/1$3,423,5002,500,000
+100.0%
0.02%
IMCR NewIMMUNOCORE HLDGS PLCads$2,538,46742,336
+100.0%
0.01%
GOOGL NewALPHABET INCcall$2,633,40022,000
+100.0%
0.01%
EWBC NewEAST WEST BANCORP INC$1,562,37329,596
+100.0%
0.01%
PLL NewPIEDMONT LITHIUM INC$1,148,42919,900
+100.0%
0.01%
GH NewGUARDANT HEALTH INC$358,35810,010
+100.0%
0.00%
PDD NewPDD HOLDINGS INCsponsored ads$289,0744,181
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-12-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP12Q3 20235.8%
APPLE INC12Q3 20234.7%
ALPHABET INC12Q3 20233.3%
NVIDIA CORPORATION12Q3 20235.4%
ALPHABET INC12Q3 20233.0%
ADVANCED MICRO DEVICES INC12Q3 20232.7%
META PLATFORMS INC12Q3 20233.3%
ARCH CAP GROUP LTD12Q3 20232.5%
AMAZON COM INC12Q3 20232.3%
CHUBB LIMITED12Q3 20231.9%

View Polar Capital Holdings Plc's complete holdings history.

Latest significant ownerships (13-D/G)
Polar Capital Holdings Plc Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Aeglea BioTherapeutics, Inc.July 28, 20233,936,1985.0%
INFINITY PHARMACEUTICALS, INC.February 14, 20232,071,2422.3%
Quotient LtdSold outFebruary 14, 202300.0%
Summit Therapeutics Inc.Sold outFebruary 14, 202300.0%
BELLUS Health Inc.February 14, 20222,500,0002.4%
Oxford Immunotec Global PLCSold outFebruary 14, 202200.0%

View Polar Capital Holdings Plc's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G2024-02-13
SC 13G2024-02-13
13F-HR/A2023-12-13
13F-HR/A2023-12-13

View Polar Capital Holdings Plc's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Polar Capital Holdings Plc's holdings